A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread
Completed
- Conditions
- Renal Cell Carcinoma
- Registration Number
- NCT03161145
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
A medical review chart study in Japan to describe the treatment patterns and outcomes of patients with kidney cancer that is unable to be removed by surgery or that has spread. The clinical data is to be abstracted using electronic data capture (eDC) from patient medical records in Japan.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 297
Inclusion Criteria
- Adults 20 years and older at the time of initial diagnosis of mRCC
- Alive or deceased as of the date of data collection
- Diagnosis of mRCC between 01-Jan-2012 and 31-Aug-2015
Read More
Exclusion Criteria
- Previously and/or currently enrolled in RCC clinical trials
- Patients have primary cancer other than renal cell cancer
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment patterns Approximately 5 years measured by retrospective data collection of treatment regimen and duration (including rate of permanent and temporary discontinuation)
Reason for terminating or switching treatment Approximately 5 years measured by data collection information available in retrospective analysis, if disclosed
Adverse Events Approximately 5 years measured by data collection
Overall survival Approximately 2 years measured by data collection in years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Local Institution
🇯🇵Tokyo, Japan